Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $438,505.91 mil
Piotroski score: 4
PE Ratio: 126.062
EPS (TTM): 2.0489
Revenue (TTM): $35.41 M
Dividend Yield: 2.6934454304842%
ROE: 95.59%
Latest News
-
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?
Sun, Jul 26, 2026 10:07 AM
-
Wall Street Week Ahead
Sun, Jul 26, 2026 6:40 AM
-
Claiming Social Security at 62 vs. Building a Dividend Bridge: Which Leaves You Richer at 75?
Sat, Jul 25, 2026 10:46 PM
-
AbbVie (ABBV) Could Be 3% Undervalued Following Epcoritamab Trial Setback
Sat, Jul 25, 2026 4:09 PM
-
Why Wall Street Can't Get Enough of This Dividend King
Sat, Jul 25, 2026 2:35 PM
-
Johnson & Johnson Is Becoming A Narrower Company Than You Bought
Sat, Jul 25, 2026 2:30 PM
-
Big Tech Earnings, Fed's Interest Rate Decision To Keep Next Week Busy
Sat, Jul 25, 2026 11:00 AM
-
SpaceX Lands With a Thud
Fri, Jul 24, 2026 10:44 PM
-
J&J's Innovative Medicine Unit Proves Its Resilience in Q2
Fri, Jul 24, 2026 2:35 PM
-
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Fri, Jul 24, 2026 2:00 PM
Key Financials
Financial data not available